IT’IS is participating in the recently approved project A Causal Role for the Voltage-Gated Calcium Channel Cav1.2 in Mediating 5G FR1 Effects on Sleep-Associated Brain Health in Humans?, funded by the Swiss Federal Office of the Environment (FOEN).
The IT'IS Foundation is pleased to announce the award of a 3-year project – Multi-Modal Optimization of 5G and 6G Hybrid Wireless and IoT Communication Networks in Switzerland – funded by the Swiss Research Foundation for Electricity and Mobile Communication
IT’IS is proud to be a partner on the project – Personalized Epidural Electrical Stimulation of The Lumbar Spinal Cord for Clinically Applicable Therapy to Restore Mobility After Paralyzing Spinal Cord Injury – with funding from the Personalized Health and Related Technologies (PHRT) strategic focus area of the ETH Domain.
Zurich43 is collaborating on the Innosuisse project – Module for Exposure Assessment of the Absorbed Power Density of Millimeter Wave Wireless Devices (Module APD) – which started in October 2020. The project is led by the Department of Information Technology and Electrical Engineering of the Swiss Federal Institute of Technology (ETH Zurich) in partnership with Schmid & Partner Engineering AG.
The IT'IS Foundation is participating on a project – Experimentally Validated Computational Pipeline of Ultrasound Propagation and Neuron-Coupling for Non-Invasive Peripheral Nervous System Stimulation – together with Profs. Silvestro Micera of the EPFL and Emmeric Tanghe of Ghent University. The project is funded by The Research Foundation – Flanders (FWO) in partnership with the Swiss National Science Foundation as part of the Weave Multilateral Lead Agency Procedure.
The EURAMET Project STASIS: Standardisation for Safe Implant Scanning in MRI was approved and started on October 1, 2022. STASIS will leverage the outcomes from the previous EURAMET EMPIR JRP 17IND01 project MIMAS, which ended successfully in 2021.
Z43 is a partner of the European SEAWave project – short for “Scientific-based Exposure and risk Assessment of radiofrequency and mm-Wave systems from children to elderly (5G and Beyond)” – funded by the HORIZON Research and Innovation Actions.
Z43 partner ZMT Zurich MedTech AG and Salvia BioElectronics B.V. join forces on the OptiStim project to develop a specialized implant as an effective therapy for both chronic migraine and chronic cluster headache.
This website applies cookies to personalize your experience and to make our site easier to navigate. By visiting the site, you are agreeing to this use and to our Privacy Policy.
